Advertisement

Disorders of Divalent Ion Metabolism

  • Farahnak Assadi

Abstract

You are asked to evaluate a family with a high incidence of hypercalciuria and nephrolithiasis, and you find that two children born to a sibling with hypercalciuria and nephrolithiasis died in early childhood of renal failure and had “calcium in their kidneys.” An extensive work-up reveals that the family members affected with hypercalciuria also demonstrated hypomagnesaemia and hypermagnesuria.

Keywords

Correct Answer Primary Hyperparathyroidism Tumor Lysis Syndrome Pediatric Nephrology Urinary Calcium Excretion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Konard M, Weber S (2003) Recent advances in molecular genetics of hereditary magnesium-losing disorders. J Am Soc Nephrol 14:249–260CrossRefGoogle Scholar
  2. Bilexikian JP, Potts JT, Jr, Fuleihan Gel H, et al. (2002) Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 87:5353–5361CrossRefGoogle Scholar
  3. Kerstetter JE, O’Brian KO, Insogna KL (2003) Low protein intake: the impact on calcium and bone homeostasis in humans. J Nutr 133:855S–861PubMedGoogle Scholar
  4. Prince MR, Erel HE, Lent RW, et al. (2003). Gadoldiamide administration causes spurious hypocalcemia. Radiology 227:639–646CrossRefPubMedGoogle Scholar
  5. Keeley FX, Jr, Tiling K, Elves A, et al. (2001) Preliminary results of a randomized controlled trial of prophylactic shock wave lithotripsy for small asymptomatic renal calyceal stones. BJU Int 87:1–8CrossRefPubMedGoogle Scholar
  6. Brater DC (2000) Pharmacology of diuretics. Am J Med Sci 319:38–50CrossRefPubMedGoogle Scholar
  7. Berenson JR (2002) Treatment of hypercalcemia of malignancy with bisphosphonates. Semin Oncol 29: (6 Suppl 21) 8–12CrossRefGoogle Scholar
  8. Nijenhuis T, Hoenderop JG, Bindels RJ (2004) Down regulation of Ca and Mg transport proteins in the kidney explains tacrolimus (FK506)-induced hypercalciuria and hypomagnesemia. J Am Soc Nephrol 15:549–557CrossRefPubMedGoogle Scholar
  9. Malloy PT, Wesley Pike J, Feldman D (1999) The vitamin D receptor and the syndrome of hereditary 1, 25 dihydroxyvitamin D-resistant rickets. Endocrine Rev 20:156–188CrossRefGoogle Scholar
  10. Chase LR, Slatopolsky E (1974) Secretion and metabolic efficiency of parathyroid hormone in patients with severe hypomagnesemia. J Clin Endocrinol Metab 38:363–371CrossRefPubMedGoogle Scholar
  11. Agus ZS (1999) Hypomagnesemia. J Am Soc Nephrol 10:1616–1622PubMedGoogle Scholar
  12. Knochel JP (1992) Hypophosphatemia and rhabdomyolysis. Am J Med 92:455–457CrossRefPubMedGoogle Scholar
  13. Cairo MS, Bishop M (2004) Tumor lysis syndrome: New therapeutic strategies and classification. British J Hematol 127:3–11CrossRefGoogle Scholar
  14. Tommaso CL, Tucci JR (1979) Metabolic studies in a case of hypocalcemia and osteoblablastic metastases. Arch Intern Med 139:238–241CrossRefPubMedGoogle Scholar
  15. Gardner EC Jr, Hersh T (1981) Primary hyperparathyroidism and gastrointestinal tract. South Med J 74:197–199PubMedGoogle Scholar
  16. Wharton B, Bishop N (2003) Rickets. Lancet 362:1389–1400CrossRefPubMedGoogle Scholar
  17. Jacobson MA, Gambertoglio JG, Aweeka FT, et al. (1991) Foscarnet-induced hypocalcemia and effects of foscarnet on calcium metabolism. J Clin Endocrinol Metab 72:1130–1135CrossRefPubMedGoogle Scholar
  18. Agus ZS (1999) Hypomagnesemia. J Am Soc Nephrol 10:1616PubMedGoogle Scholar
  19. Clarke BL, Wynne AG, Wilson DM, et al. (1995) Osteomalacia associated with adult Fanconi’s syndrome: Clinical and diagnostic features. Clin Endocrinol 43:479–490CrossRefGoogle Scholar
  20. Econs MJ, Samsa GP, Monger M, et al. (1994) X-linked hypophosphatemic rickets: a disease often unknown to affected patients. Bone Miner 24:17–24CrossRefPubMedGoogle Scholar
  21. Lotz M, Zisman E, Bartter FC (1968) Evidence for a phosphorous-depletion syndrome in man. N Engl J Med 278:409–415CrossRefPubMedGoogle Scholar
  22. Subramanian R, Khardori R (2000) Severe hypophosphatemia Pathophysiologic implications, clinical presentations, and treatment. Medicine 79:1–8CrossRefPubMedGoogle Scholar
  23. Wilkins GE, Granleese S, Hegele RG, et al. (1995) Oncogenic osteomalasia: Evidence for a humoral phosphaturic factor. J Clin Endocrinol Metab 80:1628–1634CrossRefPubMedGoogle Scholar
  24. Berenson JR (2002) Treatment of hypercalcemia of malignancy with bisphosphonates. Semin Oncol 29: (6 Suppl 21) 8–12CrossRefGoogle Scholar
  25. Wilkins GE, Granleese S, Hegele RG, et al. (1995) Oncogenic osteomalasia: Evidence for a humoral phosphaturic factor. J Clin Endocrinol Metab 80:1628–1634CrossRefPubMedGoogle Scholar
  26. Berenson JR (2002) Treatment of hypercalcemia of malignancy with bisphosphonates. Semin Oncol 29: (6 Suppl 21) 8–12CrossRefGoogle Scholar
  27. Fatemi S, Singer FR, Rude RK (1992) Effect of salmon calcitonin and etidronate on hypercalcemia of malignancy. Calcif Tissue Int 50:107–109CrossRefPubMedGoogle Scholar
  28. Frick TW, Mithofer K, Fernandez-del Castillo C, et al. (1995) Hypercalcemia causes acute pancreatitis by pancreatic secretory block, intracellular zymogen accumulation, and acinar cell injury. Am J Surg 1:167–172CrossRefGoogle Scholar
  29. Heath H 3rd (1991) Clinical spectrum of primary hyperparathyroidism. Evolution with changes in medical practice and technology. J Bone Miner Res 6 (suppl 2); S63–70CrossRefPubMedGoogle Scholar
  30. Lins LE (1978) Reversible renal failure caused by hypercalcemia. A retrospective study. Acta Med Scand 203: 309–314Google Scholar
  31. Major P, Lortholary A, Hon J, et al. (2001) Zolendronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. J Clin Oncol 19:558–567PubMedGoogle Scholar
  32. Sheck CC, Natkunam A, Tsang V, et al. (1990) Incidence, causes, and mechanism of hypercalcemia in a hospital population in Hong Kong. Q J Med 77:1277–1285Google Scholar
  33. Suki WN, Yium JJ, Van Minden M, et al. (1970) Acute treatment of hypercalcemia with furosemide. N Engl J Med 283:836–840CrossRefPubMedGoogle Scholar
  34. Wilson KS, Alexander S, Chiaolm IA (1982) Band keratopathy in hypercalcemia of myeloma. Can Med Ass J 126:1314PubMedGoogle Scholar
  35. Winsneski LA (1990) Salmon calcitonin in the acute management of hypercalcemia. Calcif Tissue Int 46: S26–30CrossRefGoogle Scholar
  36. Heath H 3rd (1991) Clinical spectrum of primary hyperparathyroidism. Evolution with changes in medical practice and technology. J Bone Miner Res 6 (suppl 2); S63–70CrossRefPubMedGoogle Scholar
  37. Spierstein AE, Shen W, Chan AK, et al. (1992) Normocalcemic hyperparathyroidism: Biochemical and symptoms profiles before and after surgery. Arch Surg 127:1157–1166Google Scholar
  38. Agus ZS (1999) Hypomagnesemia. J Am Soc Nephrol 10:1616PubMedGoogle Scholar
  39. Al-Ghamdi SM, Cameron EC, Sutton RA (1994) Magnesium deficiency: Pathophysiologic and clinical overview. Am Kidney Dis 24:737Google Scholar
  40. Benigno V, Canonica CS, Bettinelli A, et al. (2000) Hypomagnesemia-hypocalciuria-nephrocalcinosis: A report of nine cases and a review. Nephrol Dial Transplant 15:605–610CrossRefPubMedGoogle Scholar
  41. Booth BE, Johnson A (1974) Hypomagnesemia due to renal tubular defect in reabsorption of magnesium. J Pediatr 85:350CrossRefPubMedGoogle Scholar
  42. Evans RA, Carter JN, George CRP, et al. (1981) The congenital ‘‘magnesium-losing’’ kidney. Q J Med 50:30Google Scholar
  43. Elisaf M, Panteli K, Theodorou J, et al. (1997) Fractional excretion of magnesium in normal subjects and in patients with hypomagnesemia. Magnes Res 10:315–320PubMedGoogle Scholar
  44. Evans RA, Carter JN, George CRP, et al. (1981) The congenital ‘‘magnesium-losing’’ kidney. Q J Med 50:30Google Scholar
  45. Kamel KS, Harvey E, Douek K, et al. (1998) Studies on the pathogenesis of hypokalemia in Gitelman’s syndrome: Role of bicarbonate and hypomagnesemia. Am J Nephrol 18:42–49CrossRefPubMedGoogle Scholar
  46. Meij IC, Koenderink JB, van Bokhoven H, et al. (2000) Dominant isolated renal magnesium loss is caused by missing of the Na+-K+ ATPase gamma-subunit. Nat Genet 26:265–266CrossRefPubMedGoogle Scholar
  47. Takeuchi K, Kure T, Taniyama Y, et al. (1996) Association of a mutation in thiazide-sensitive Na-Cl cotransporter with familial Gitelman’s syndrome. J Clin Endocrinol Metab 81:4496–4499CrossRefPubMedGoogle Scholar
  48. Whang R, Whang DD, Ryan MP (1992) Refractory potassium depletion> A consequence of magnesium deficiency. Arch Intern Med 152:40CrossRefPubMedGoogle Scholar
  49. Takeuchi K, Kure S, Kato T, et al. (1996) Association of a mutation in thiazide-sensitive Na-Cl cotransporter with familial Gitelman’s syndrome. J Clin Endocrinol Metab 12:4496–4499CrossRefGoogle Scholar
  50. Benigno V, Canonica CS, Bettinelli A, et al. (2000) Hypomagnesemia-hypocalciuria-nephrocalcinosis: A report of nine cases and a review. Nephrol Dial Transplant 15:605–610CrossRefPubMedGoogle Scholar
  51. Choist IN, Steinberg SF, Tropper PJ, et al. (1984) The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects. N Engl J Med 310:1221–1225CrossRefGoogle Scholar
  52. Kamel KS, Harvey E, Douek K, et al. (1998) Studies on the pathogenesis of hypokalemia in Gitleman’s syndrome: Role of bicarbonate and hypomagnesemia. Am J Nephrol 18:42–49CrossRefPubMedGoogle Scholar
  53. A gene (PEX) with homologies to endopeptidases is mutated in patients with x-linked hypophosphatemic rickets (The HYP Consortium. Nat Genet 1995; 11:130)Google Scholar
  54. Selby PL, Davies M, Marks JS, et al. (1995) Vitamin D intoxication causes hypercalcemia by increased bone resorption which responds to pamidronate. Clin Endocrinol 43:531–536CrossRefGoogle Scholar
  55. Syed MA, Horwitz MJ, Tedesco MB, et al. (2001) Parathyroid hormone-related protein (1–36) stimulates renal tubular calcium reabsorption in normal human volunteers: Implications for the pathogenesis of humoral hypercalcemia of malignancy. J Clin Endocrinol Metab 86:1525–1531CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Farahnak Assadi
    • 1
  1. 1.Rush University Medical CenterChicago

Personalised recommendations